238.32
Veeva Systems Inc stock is traded at $238.32, with a volume of 658.48K.
It is up +2.30% in the last 24 hours and up +4.76% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$233.00
Open:
$236.44
24h Volume:
658.48K
Relative Volume:
0.51
Market Cap:
$38.84B
Revenue:
$2.75B
Net Income/Loss:
$714.14M
P/E Ratio:
55.04
EPS:
4.33
Net Cash Flow:
$1.09B
1W Performance:
-1.00%
1M Performance:
+4.76%
6M Performance:
+5.12%
1Y Performance:
+16.91%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
VEEV
Veeva Systems Inc
|
238.37 | 39.05B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
TEM
Tempus Ai Inc
|
65.30 | 11.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
100.94 | 8.46B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
51.84 | 10.10B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
39.15 | 6.85B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-23-25 | Downgrade | Goldman | Buy → Sell |
Dec-20-24 | Initiated | Stephens | Overweight |
Dec-04-24 | Initiated | Mizuho | Outperform |
Nov-19-24 | Initiated | Scotiabank | Sector Perform |
Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
Aug-27-24 | Reiterated | Citigroup | Buy |
Jul-09-24 | Initiated | BTIG Research | Buy |
Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-13-23 | Initiated | Jefferies | Buy |
Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
Mar-17-23 | Downgrade | Truist | Buy → Hold |
Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
Dec-06-22 | Initiated | Cowen | Market Perform |
Dec-02-22 | Reiterated | Needham | Buy |
Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-27-22 | Initiated | Oppenheimer | Outperform |
Jun-23-22 | Initiated | Goldman | Buy |
Jun-21-22 | Resumed | Guggenheim | Buy |
Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-28-22 | Initiated | Truist | Buy |
Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-01-21 | Resumed | Stifel | Buy |
Sep-02-21 | Reiterated | BofA Securities | Buy |
Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
Sep-02-21 | Reiterated | Needham | Buy |
Sep-02-21 | Reiterated | UBS | Neutral |
Jul-21-21 | Initiated | Cowen | Outperform |
Mar-31-21 | Upgrade | UBS | Sell → Neutral |
Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
Oct-14-20 | Resumed | UBS | Sell |
Aug-28-20 | Reiterated | Needham | Buy |
Jul-23-20 | Initiated | FBN Securities | Outperform |
Jul-07-20 | Initiated | Stephens | Overweight |
Jun-08-20 | Initiated | Citigroup | Buy |
May-29-20 | Reiterated | Needham | Buy |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Feb-19-20 | Initiated | Robert W. Baird | Outperform |
Feb-14-20 | Initiated | Piper Sandler | Overweight |
Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
Aug-28-19 | Reiterated | Needham | Buy |
Jun-07-19 | Initiated | Goldman | Neutral |
May-30-19 | Reiterated | BofA/Merrill | Buy |
May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Apr-17-19 | Reiterated | Needham | Buy |
Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Biopharma Leaders Connect to Advance Development and Manufacturing at Veeva R&D and Quality Summit Europe - PR Newswire
Veeva Systems (VEEV) Reports Earnings Tomorrow: What To Expect - FinancialContent
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet - Nasdaq
Head-To-Head Survey: Veeva Systems (NYSE:VEEV) & Rapid7 (NASDAQ:RPD) - Defense World
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Veeva Announces Fiscal 2024 Second Quarter Results - Seeking Alpha
Veeva (VEEV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold - The Motley Fool
TMF Trend Report: 6 Trends of 2025 | Veeva - Veeva
Veeva Systems (VEEV) to Release Quarterly Earnings on Wednesday - Defense World
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Spotline V-Assure Platform Enables Pre-Validation for Veeva Basics Releases - PR Newswire
More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Veeva
More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality | VEEV Stock News - GuruFocus
Veeva Systems (VEEV) Faces Pressure After Takeda Chooses Salesfo - GuruFocus
Veeva down after Takeda chooses Salesforce Life Sciences Cloud - Seeking Alpha
Veeva Systems Inc. (NYSE:VEEV) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Saudi Arabia Pharmaceutical Quality Management Software Market Forecast and Opportunities, 2030F Featuring MasterControl, AmpleLogic, Pilgrim, Sparta Systems, Dassault, Veeva Systems, and Ideagen - GlobeNewswire
Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Veeva Systems' (NYSE:VEEV) three-year earnings growth trails the respectable shareholder returns - simplywall.st
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today - Benzinga
For Third Year in a Row, Veeva MedTech Recognized as Best Overall MedTech Software - Veeva
Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know - Yahoo Finance
2 Reasons to Like VEEV and 1 to Stay Skeptical - Yahoo Finance
Advancing the Future of Unified Engagement - Veeva
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025 | VEEV Stock News - GuruFocus
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025 - Stock Titan
Life Sciences Leaders Advance Unified Engagement at Veeva Commer - GuruFocus
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit | VEEV Stock News - GuruFocus
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit - marketscreener.com
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit – Company Announcement - Financial Times
Veeva: Our 2025 Software Pick Just Keeps Winning (NYSE:VEEV) - Seeking Alpha
Major Pharma Leaders Join Veeva to Reveal Game-Changing AI Integration for Commercial Operations - Stock Titan
2024 Veeva Commercial Summit | Veeva - Veeva
June 2026 Options Now Available For Veeva Systems (VEEV) - Nasdaq
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - MSN
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Benzinga
Veeva Systems (NYSE:VEEV) Unveils Veeva AI To Boost Productivity In Life Sciences - Yahoo Finance
Werner Engelbrecht - AI Business
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Science - GuruFocus
Veeva Systems Introduces Veeva AI - Contract Pharma
Announcing Veeva AI | VEEV Stock News - GuruFocus
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Sciences Automation | VEEV Stock News - GuruFocus
Announcing Veeva AI - marketscreener.com
Here's Why You Should Add Veeva Stock to Your Portfolio Now - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Peering Into Veeva Systems's Recent Short Interest - Benzinga
Veeva (VEEV) Price Target Trimmed by Piper Sandler Amid Industry Challenges | VEEV Stock News - GuruFocus
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):